GlaxoSmithKline Pakistan Ltd
GlaxoSmithKline Pakistan Ltd operates in Pharmaceuticals.
Market Cap & Net Worth: GlaxoSmithKline Pakistan Ltd (GLAXO)
GlaxoSmithKline Pakistan Ltd (KAR:GLAXO) has a market capitalization of $10.95K (PKRs3.05 Million) as of March 19, 2026. Listed on the KAR stock exchange, this Pakistan-based company holds position #44955 globally and #62 in its home market, demonstrating a 5.37% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GlaxoSmithKline Pakistan Ltd's stock price PKRs308.82 by its total outstanding shares 9889 (9.89K).
GlaxoSmithKline Pakistan Ltd Market Cap History: 2015 to 2026
GlaxoSmithKline Pakistan Ltd's market capitalization history from 2015 to 2026. Data shows growth from $5.30K to $10.95K (7.32% CAGR).
Index Memberships
GlaxoSmithKline Pakistan Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Karachi 100
KSE100
|
$2.22 Million | 0.46% | #26 of 100 |
|
Karachi All Share
KSI
|
$3.34 Million | 0.30% | #55 of 448 |
Weight: GlaxoSmithKline Pakistan Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
GlaxoSmithKline Pakistan Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GlaxoSmithKline Pakistan Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of GLAXO by Market Capitalization
Companies near GlaxoSmithKline Pakistan Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to GlaxoSmithKline Pakistan Ltd by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3465 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #6393 globally with a market cap of $1.27 Billion USD ( ₩1.86 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7113 globally with a market cap of $1.05 Billion USD ( ₩1.54 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #7795 globally with a market cap of $890.75 Million USD ( ₩1.30 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3465 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩739000.00 |
| #6393 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.27 Billion | ₩89200.00 |
| #7113 | ST Pharm Co.Ltd | KQ:237690 | $1.05 Billion | ₩153400.00 |
| #7795 | Oscotec Inc | KQ:039200 | $890.75 Million | ₩54900.00 |
GlaxoSmithKline Pakistan Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, GlaxoSmithKline Pakistan Ltd's market cap moved from $5.30K to $ 10.95K, with a yearly change of 7.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | PKRs10.95K | -20.77% |
| 2025 | PKRs13.82K | -1.80% |
| 2024 | PKRs14.08K | +378.26% |
| 2023 | PKRs2.94K | -5.45% |
| 2022 | PKRs3.11K | -32.34% |
| 2021 | PKRs4.60K | -25.83% |
| 2020 | PKRs6.20K | +23.56% |
| 2019 | PKRs5.02K | +49.78% |
| 2018 | PKRs3.35K | -31.45% |
| 2017 | PKRs4.89K | -24.71% |
| 2016 | PKRs6.49K | +22.44% |
| 2015 | PKRs5.30K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of GlaxoSmithKline Pakistan Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.95K USD |
| MoneyControl | $10.95K USD |
| MarketWatch | $10.95K USD |
| marketcap.company | $10.95K USD |
| Reuters | $10.95K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.